28 August 2025
Sclerosis | Aims and Scope Update

To further enhance the quality of Sclerosis (ISSN: 2813-3064) and the papers published in it, under the guidance of our Editor-in-Chief, Dr. Maurizio A. Leone, the journal has updated and revised its aims and scope. The original scope and the updated version are listed below.

Aims (new version):

Aims (old version):

Sclerosis (ISSN 2813-3064) is an international and interdisciplinary peer-reviewed open access journal that is published quarterly online by MDPI. Sclerosis provides an advanced forum for studies on all aspects of sclerosis and related diseases. It publishes research papers, reviews, communications, editorials, case reports, opinions, etc. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the maximum length of the papers.

Sclerosis (ISSN 2813-3064) is an international and interdisciplinary peer-reviewed open access journal, published quarterly online by MDPI. Sclerosis provides an advanced forum for studies on all aspects of sclerosis and related diseases. It publishes research papers, reviews, and communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the maximum length of the papers.

Scope (new version):

Scope (old version):

  • Multiple sclerosis;
  • Systemic sclerosis;
  • Amyotrophic lateral sclerosis;
  • Neuromyelitis optica spectrum disorder;
  • Atherosclerosis;
  • Focal segmental glomerulosclerosis;
  • Hippocampal sclerosis;
  • Lichen sclerosus;
  • Osteosclerosis;
  • Otosclerosis;
  • Primary lateral sclerosis;
  • Primary sclerosing cholangitis;
  • Tuberous sclerosis.
  • Amyotrophic lateral sclerosis;
  • Atherosclerosis;
  • Focal segmental glomerulosclerosis;
  • Hippocampal sclerosis;
  • Lichen sclerosus;
  • Multiple sclerosis;
  • Osteosclerosis;
  • Otosclerosis;
  • Primary lateral sclerosis;
  • Primary sclerosing cholangitis;
  • Systemic sclerosis;
  • Tuberous sclerosis.

For more detailed information, please visit the following link: https://www.mdpi.com/journal/sclerosis/about.

Sclerosis Editorial Office

Back to TopTop